Polymorphism and stability of norfloxacin, (1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinil)-3-quinolinocarboxylic acid

Norfloxacin was studied by thermal methods (TG and DSC), X-ray powder diffraction, and by FT-IR, UV-VIS and NMR spectroscopy. The drug substance can be prepared in two different crystalline forms and in amorphous state, depending on the experimental conditions of preparation. DSC examinations were carried out at various heating rates and by cycling the samples in the temperature range 50°–250°C. The unstable crystalline form undergoes two irreversible solid-solid phase transitions at 176.5° and 197.6°C. The polymorph melts in the temperature range 218.5°–220.0°C.

---

Zusammenfassung Norfloxacin wurde mittels thermischer Methoden (TG und DSC), weiterhin mittels der Debye-Scherrer-Methode und FTIR-, UV-VIS-und NMR-Spektroskopie untersucht. Je nach den experimentellen Bedingungen bei der Herstellung kann die Wirkstoffsubstanz in zwei verschiedenen kristallinen und in einer amorphen Form hergestellt werden. Die DSC-Untersuchungen wurden bei zahlreichen Aufheizgeschwindigkeiten und durch abwechselnden Temperaturwechsel zwischen Raum- und Schmelztemperatur durchgeführt. Die unstabile kristalline Form unterliegt zwei irreversiblen Feststoff-Feststoff-Umwandlungen bei 176.5° und bei 195.6°C. Das polymorphe Material schmilzt im Temperaturbereich 218.5°–220.0°C.

     

Polymorphic transformation of indomethacin in precirol solid dispersion system

The polymorphic transformation of indomethacin (IMC) in the presence of Precirol during heating was investigated by differential scanning calorimetry (DSC), infrared (IR) spectroscopy, microscopic Fourier transform infrared (FT-IR)/DSC system, and powder X-ray diffractometry with heating. The results indicate that in the presence of Precirol the original γ form of IMC was first transformed to a transition state, and then to a new polymorph by heating or exposure to IR radiation. The transition state of the melted sample gave three endothermic peaks, at 34, 48 and 127°C, and one exothermic peak, at 54°C. The stable melted sample exhibited two endothermic peaks, at 58 and 127°C, which were due to the fusion of Precirol and the new polymorph of IMC, respectively. This new polymorph of IMC also exhibited two specific IR absorption peaks, at 1693 and 1675 cm^?1. Microscopic FT-IR/DSC was used to examine the correlation between the structural transformation and its thermal response, and demonstrated the existence of the transition state of the melted sample. X-ray diffractometry with heating confirmed the appearance of the new polymorph of IMC in the presence of Precirol after heating.     

Thermodynamic Analysis of DSC Data for Acetaminophen Polymorphs

This article provides a thermodynamic analysis of DSC data for acetaminophen polymorphic forms I and II by measurement of heat capacity. Form I is found to have lower heat capacity and free energy and hence better stability than Form II down to at least –30°C. The transition temperature below which Form II becomes more stable was determined to be less than –120°C. Form I is more stable than Form II as a consequence of its higher entropy, since its crystallographic packing arrangement is of larger energy. This revised version was published online in August 2006 with corrections to the Cover Date.     

Study of the polymorphic behaviour of some local anesthetic drugs

The local anesthetic drug tetracaine hydrochloride is described in the Europ. Pharmacopea with a melting point of 148°C or with a range of 134 to 147°C due to the melting points of two other forms. The polymorphic behaviour of tetracaine hydrochloride has been studied by using thermal treatments, storage at 92% r.h., crystallizations and equilibrations with saturated solutions. Samples were characterized by X-ray diffraction, IR, thermal analysis and elemental analysis. Since some findings were difficult to interpret, temperature resolved X-ray diffraction was used additionally for the understanding of the thermal behaviour of tetracaine hydrochloride. In this study the polymorphic behaviour of some other local anesthetic drugs is compared. Ten different forms of tetracaine hydrochloride: six anhydrous crystalline forms, an amorphous form, a hemihydrate, a monohydrate and a tetrahydrate were identified. The relationships between all forms are given. The heating curve of the commercial form 1 is very dependent on the heating rate. This anhydrous form 1 is the thermodynamic stable modification at ambient temperature. The form 2 is reversibly enantiotrope to form 1. The four other modifications called 3, 4, 5 and 6 are monotropes of form 1. Only forms 1 and 5 are stable at ambient temperature. Form 1 is hygroscopic only at high humidity level of 92% r.h., form 5 is hygroscopic at 61% r.h. Both transform into the monohy-drate. No polymorphic forms of tetracaine base, dibucaine hydrochloride, procaine hydrochloride or prilocaine hydrochloride were found. The commercial form of bupivacaine hydrochloride is a monohydrate. Thermal treatment at 200°C gives one anhydrous form. As demonstrated by temperature resolved X-ray diffraction two other forms are detected by heating and cooling processes between 100 and 170°C. Equilibrations and crystallization experiments show that solvates are easily obtained in different solvents. Temperature resolved X-ray diffraction is a very efficient tool as a support to DSC for the identification of the transition processes and interpretation of thermal events and thermodynamic relationships. Equilibration experiments are very adequate to find out the thermodynamically stable form at ambient temperature (solvent mediated transitions).     

Investigation of accidental explosion of raw garbage composting system

Cellulose, chitosan and piroxicam were investigated by TG and DSC at heating up to 215°C, and by X-ray powder diffraction before and after the heating. Dehydration of cellulose and chitosan comes to the end near 160°C. Thermal decomposition of chitosan starts at the final stage of its dehydration, and the mass losses after these two reactions overlap with one another. Enthalpy of dehydration is 47.1±2.4 kJ mol^–1 of water for cellulose and 46.2±2.0 kJ mol^–1 for chitosan. Thermal decomposition of chitosan is an exothermic process. Crystal structure of cellulose after heating remains unchanged, but that of chitosan contracts. Piroxicam melts at 200.7°C with the enthalpy of melting 35 kJ mol^–1. Heat capacity of the liquid phase is greater than that of the solid phase by approximately 100 J mol^–1K^–1. Cooled back to ambient temperature, piroxicam remains glassy for a long time, crystallizing slowly back into the starting polymorph.     

Crystal polymorphism of local anaesthetic drugs

Crystal polymorphs of pramocaine hydrochloride (PRCNC) and pramocaine (PRCN) free base were produced and characterized by means of thermomicroscopy, differential scanning calorimetry (DSC), FTIR- and FT-Raman-spectroscopy as well as X-ray-powder diffractometry. The relative thermodynamic stabilities of all forms were determined and are represented in semi-schematic energy/temperature diagrams. PRCN, which is a viscous liquid at room temperature and insoluble in water, was found to exist in two different crystal forms with the melting points 23.5°C (mod. I°) and 12.5°C (mod. II). The water-soluble PRCNC crystallizes in three different crystal modifications. Mod. II° is the thermodynamically stable form at room temperature and is present in commercial products. This form is obtained by crystallization from solvents and transforms on heating at about 95°C into the high temperature form mod. I which melts at 171.0°C. Both compounds show conformational polymorphism with forms of low kinetic stability. This revised version was published online in July 2006 with corrections to the Cover Date.     

Melting Curves of Terfenadine Crystallized from Different Solvents

Several samples of terfenadine prepared by crystallization from different solvents under different experimental conditions were studied. The DSC curves obtained at a heating rate of 1°C min⁻¹ afforded the temperature of melting and the mole fractions of the components of each sample. Certain of the samples were composed of two solid phases mixed in molar ratios varying between nearly one and a single structural form. Three polymorphic forms were identified. This revised version was published online in August 2006 with corrections to the Cover Date.     

Polymorphism in polymers. I. The equilibrium melting temperature of two crystalline modifications of trans-1,4-polyisoprene

Dilatometric, calorimetric, and dissolution studies have been made of two crystalline modifications of trans-1,4-polyisoprene in order to determine their equilibrium melting temperatures. This parameter is of fundamental importance in the formal treatment of polymorphism in crystalline polymers. A consistent set of thermodynamic parameters has been derived for both crystalline modifications. The equilibrium melting temperature of the polymorph, which was previously observed to melt from carefully crystallized bulk material at 64°C, was calculated to be at least 82.4°C. The other form, which melts from the bulk at 74°C, has an equilibrium melting temperature of 79.5 ± 0.5°C. The trans-1,4-polyisoprene, crystallized by stirring n-butyl acetate solutions at 49°C, was found by x-ray diffraction to be in the first form and melts at 81.2 ± 0.5°C when very slow heating rates are applied. This melting temperature is very close to the independently derived equilibrium melting temperature and lends support to the possibility that extended chain crystals are present in these solution crystallized crystals. Using the newly found melting temperatures of the two crystalline modifications it can be derived from the free energies of fusion that the first crystalline form is more stable at temperatures above approximately 66°C, whereas the other form is more stable below this temperature.     

Physico-chemical characterization of an active pharmaceutical ingredient

The physico-chemical properties and polymorphism of a new active pharmaceutical ingredient entity has been analyzed and the gain of knowledge during the chemical development of the substance is described. Initial crystallization revealed an anhydrous crystal form with good crystallinity and a single, sharp DSC melting peak at 171°C and a straightforward development of this crystal form seemed possible. However, during polymorphism screening, new crystalline forms were detected that were often analyzed as mixtures of crystal forms. The process of characterization and identification of the different crystalline forms and its thermodynamical relationship has been supported by a combination of experimental and computational work including determination of the three-dimensional structures of the crystal forms. The crystal structure of one polymorphic form was solved by single crystal X-ray structure analysis. Unfortunately, Mod B resisted in formation of suitable single crystals, but its structure could be solved by high resolution powder diffraction data analysis using synchrotron radiation. Calculation of the theoretical X-ray powder diffraction pattern from three dimensional crystal coordinates allowed an unambiguous identification of the different crystalline forms. Two polymorphic crystal forms of the API-CG3, named Mod A and Mod B, are enantiotropic whereas Mod B is the most stable polymorph at room temperature up to about 50°C and Mod A at temperatures above 50°C. The mechanism of the solid-solid transition can be explained by analyzing the molecular packing information gained from the single crystal structures. A third crystalline form with the highest melting peak turned out to be not a polymorphic or pseudopolymorphic crystal modification of our API-CG3 but a chemically different substance. This revised version was published online in July 2006 with corrections to the Cover Date.     

Thermal and X-ray analysis of racemic bupivacaine hydrochloride

An amide-type local anesthetic drug, bupivacaine hydrochloride (BupiHCl), in the form of racemate is listed in the European and American pharmacopoeias and continues to be used in medicine. Thermal and X-ray analysis of commercial BupiHCl monohydrate was performed by differential scanning calorimetry with thermogravimetry, hot stage microscopy, and X-ray diffraction. Endothermic dehydration occurs at the temperature range of 73–130 °C for DSC–TG 111 (Setaram) and at 83–150 °C for DSC 404 (Netzsch). Both curves at 2 and 10 °C min⁻¹ clearly reflect phase transformation of anhydrous Form I into II before reaching the melting point. A well-defined exothermic phase transition of BupiHCl was detected at a lower heating rate. Temperature-resolved X-ray diffraction in conjunction with DSC led to determining a similarity between the obtained thermal events. Microscopic investigation also confirmed the above-mentioned transformations.     

Pharmaceutical physical form characterisation with fast (>200 °C min<Superscript>−1</Superscript>) DSC heating rates

Differential scanning calorimetry (DSC) has many applications during preformulation screening of new drug candidates, but definitive assignment of peaks to specific events in the sample is difficult without supplementary data from other techniques. To some extent these problems can be overcome by running multiple experiments at different heating rates. Typically 2 and 20 °C min⁻¹ are indicated. However, modern instruments are capable of achieving much faster heating rates (up to 750 °C commercially); with this extended range comes a new capacity for investigating the physical form of materials. Here, the use of fast DSC heating rates for materials characterisation is explored, focussing on determination of melting temperatures, glass formation and polymorph screening.     

Non-isothermal kinetic study of the thermal decomposition of diaminoglyoxime and diaminofurazan

Data on the thermal stability of organic materials such as diaminofurazan (DAF) and diaminoglyoxime (DAG) was required in order to obtain safety information for handling, storage and use. These compounds have been shown to be a useful intermediate for the preparation of energetic compounds. In the present study, the thermal stability of the DAF and DAG was determined by differential scanning calorimetery (DSC) and simultaneous thermogravimetery-differential thermal analysis (TG-DTA) techniques. The results of TG analysis revealed that the main thermal degradation for the DAF and DAG occurs in the temperature ranges of 230–275°C and 180–230°C, respectively. On the other hand, the TG-DTA analysis of compounds indicates that DAF melts (at about 182°C) before it decomposes. However, the thermal decomposition of the DAG started simultaneously with its melting. The influence of the heating rate (5, 10, 15 and 20°C min⁻¹) on the DSC behaviour of the compounds was verified. The results showed that, as the heating rate was increased, decomposition temperatures of the compounds were increased. Also, the kinetic parameters such as activation energy and frequency factor for the compounds were obtained from the DSC data by non-isothermal methods proposed by ASTM E698 and Ozawa. Based on the values of activation energy obtained by ASTM and Ozawa methods, the following order in the thermal stability was noticed: DAF>DAG.     

Polymorphism and melt crystallisation of racemic betaxolol, a β-adrenergic antagonist drug

We report the polymorphic behaviour, in melt cooling experiments, of racemic betaxolol, a low aqueous solubility selective β₁-adrenergic antagonist drug with a flexible molecular structure. A multidisciplinary approach is employed, using thermal analysis (differential scanning calorimetry, polarised light thermomicroscopy), spectroscopic methods (infrared spectroscopy, magic angle spinning ¹H NMR) and X-ray powder diffraction. A glass phase is obtained, T _g ~ ?10 °C, on cooling the melt, unless the cooling rate is ≤0.5 °C min^?1, while a new metastable form, polymorph II, T _fus = 33 °C, is generated in subsequent heating runs in a two step process. Although either partial crystallisation from the melt in the first step or the formation of an intermediate, metastable, low ordered phase may explain these observations, our results favour the second hypothesis. The stable polymorph I, T _fus = 69 °C, which crystallizes on further heating after form II melting, has also been obtained either from polymorph II or from the molten phase, on standing at 25 °C. The racemic betaxolol crystalline phases are found to exhibit some degree of disorder.     

Studies on the thermal behavior and decomposition kinetic of drugs cetirizine and simvastatin

Understanding the response of drugs and their formulations to thermal stresses is an integral part of the development of stable medicinal products. In the present study, the thermal degradation of two drug samples (cetirizine and simvastatin) was determined by differential scanning calorimetery (DSC) and simultaneous thermogravimetery/differential thermal analysis (TG/DTA) techniques. The results of TG analysis revealed that the main thermal degradation for the cetirizine occurs during two temperature ranges of 165–227 and 247–402 °C. The TG/DTA analysis of simvastatin indicates that this drug melts (at about 143 °C) before it decomposes. The main thermal degradation for the simvastatin occurs during two endothermic behaviors in the temperature ranges of 238–308 and 308–414 °C. The influence of the heating rate (5, 10, 15, and 20 °C min^?1) on the DSC behavior of both the drug samples was verified. The results showed that as the heating rate was increased, decomposition temperatures of the compounds were increased. Also, the kinetic parameters such as activation energy and frequency factor for the compounds were obtained from the DSC data by non-isothermal methods proposed by ASTM E696 and Ozawa. Based on the values of activation energy obtained by ASTM E696 method, the values of activation energy for cetirizine and simvastatin were 120.8 and 170.9 kJ mol^?1, respectively. Finally, the values of ΔS ^#, ΔH ^#, and ΔG ^# of their decomposition reaction were calculated.     

Hysteresis in the β–α phase transition in silver iodide

The nature of the β to α phase transition in silver iodide was investigated by conventional and modulated temperature DSC and dielectric property measurements. On cooling, the high temperature phase remained stable 2.5°C below its normal transition temperature even at a very slow cooling rate 0.2°C h^–1. Dielectric property measurements under conventional and microwave heating suggested an anomalous effect of the latter on the β to α phase transition in this material.     

Thermal behavior of drugs

Data on the thermal stability of drugs was required to obtain information for handling, storage, shelf life and usage. In this study, the thermal stability of two nonsteroidal anti-inflammatory drugs (NSAIDs) was determined by differential scanning calorimetry (DSC) and simultaneous thermogravimetery/differential thermal analysis (TG/DTA) techniques. The results of TG analysis revealed that the main thermal degradation for the naproxen and celecoxib occurs in the temperature ranges of 196–300 and 245–359 °C, respectively. The TG/DTA analysis of compounds indicates that naproxen melts (at about 158.1 °C) before it decomposes. However, the thermal decomposition of the celecoxib started about 185 °C after its melting. The influence of the heating rate (5, 10, 15, and 20 °C min⁻¹) on the DSC behavior of the both drug samples was verified. The results showed that, as the heating rate was increased, decomposition temperatures of the compounds were increased. Also, the kinetic parameters such as activation energy and frequency factor for the compounds were obtained from the DSC data by non-isothermal methods proposed by ASTM E696 and Ozawa. Based on the values of activation energy obtained by various methods, the following order for the thermal stability was noticed: naproxen > celecoxib. Finally, the values of ΔS ^#, ΔH ^#, and ΔG ^# of their decomposition reaction were calculated.     

Study on melting and polymorphic behavior of poly(decamethylene terephthalamide)

This work describes the melting and polymorphic behavior of poly(decamethylene terephthalamide) (PA 10T). Both solution‐crystallized (SC) and melt‐crystallized (MC) PA 10T show double melting endotherms in DSC. The SC crystal form melts at 260–300°C giving the first melting endotherm, and meanwhile undergoes a polymorphic transition forming the MC crystal form. The subsequent melting of the MC crystal form gives the second melting endotherm at 300–325°C. This irreversible polymorphic transition is confirmed by variable‐temperature WAXD and IR. Dynamic mechanical thermal analysis (DMTA) shows a glass transition temperature (T_g) at 127°C and the presence of an α′ transition at 203°C (0.1 and 1 Hz). This transition could be confirmed by DSC and variable‐temperature WAXD experiments. The α′ transition correlates with a reversible thermal process and a sudden change in intersheet spacing. © 2019 Wiley Periodicals, Inc. J. Polym. Sci., Part B: Polym. Phys. 2019 , 57, 465–472     

Evaluation of the physical stability and local crystallization of amorphous terfenadine using XRD-DSC and micro-TA

It is very difficult to follow rapid changes in polymorphic transformation and crystallization and to estimate the species recrystallized from the amorphous form. The aim of this study was to clarify the structural changes of amorphous terfenadine and to evaluate the polymorphs crystallized from amorphous samples using XRD-DSC and an atomic force microscope with a thermal probe (micro-TA). Amorphous samples were prepared by grinding or rapid cooling of the melt. The rapid structural transitions of samples were followed by the XRD-DSC system. On the DSC trace of the quenched terfenadine, two exotherms were observed, while only one exothermic peak was observed in the DSC scan of a ground sample. From the in situ data obtained by the XRD-DSC system, the stable form of terfenadine was recrystallized during heating of the ground amorphous sample, whereas the metastable form was recrystallized from the quenched amorphous sample and the crystallized polymorph changed to the stable form. Obtained data suggested that recrystallized species could be related to the homogeneity of samples. When the stored sample surface was scanned by atomic force microscopy (AFM), heterogeneous crystallization was observed. By using micro-TA, melting temperatures at various points were measured, and polymorph forms I and II were crystallized in each region. The percentages of the crystallized form I stored at 120 and 135 °C were 47 and 79%, respectively. This result suggested that increasing the storage temperature increased the crystallization of form I, the stable form, confirming the temperature dependency of the crystallized form. The crystallization behavior of amorphous drug was affected by the annealing temperature. Micro-TA would be useful for detecting the inhomogeneities in polymorphs crystallized from amorphous drug.     

Characterization of polymorphs of a novel quinolinone derivative, TA-270 (4-hydroxy-1-methyl-3-octyloxy-7-sinapinoylamino-2(1H)-quinolinone)

The polymorphic forms and amorphous form of TA-270 (4-hydroxy-1-methyl-3-octyloxy-7-sinapinoylamino-2(1H)-quinolinone), a newly developed antiallergenic compound, were characterized by powder X-ray diffractometry, thermal analysis, infrared spectroscopy and solid state 13C-NMR. The intrinsic dissolution rates of polymorphic forms were measured using the rotating disk method at 37 degrees C. The dissolution rates correlated well with the thermodynamic stability of each polymorphic form. These dissolution properties were clearly reflected in the oral bioavailability of TA-270 in rats. The transition behavior for each polymorph and for the amorphous form was studied under the high temperature and humidity conditions. The beta- and delta-forms were transformed into the alpha-form by heating. The amorphous form was also easily crystallized into alpha-form by heating, however it was relatively stable under humidified conditions. The internal molecular packing of each polymorph was estimated from IR and solid state NMR spectral analysis.